Clinicians

When the Test Says Normal but the Pain Does Not

COVID Vaccines Still Kept Adults Out of Hospital. The Evidence Should Matter.

Gene therapy is entering cardiology. Friedreich ataxia shows why rare heart disease may be the first test

Triglycerides are back in the spotlight. Europe is reviewing Sobi’s olezarsen for severe risk.

When Brain Surgery Is Too Risky, Patients Still Need a Molecular Answer

Germany Is Paying the Price for Leaving Tardive Dyskinesia Behind

A Rare Childhood Ataxia Gets Real Phase III Evidence

A Year of Measles in Utah Is What Lost Protection Looks Like

Europe’s next stroke bet: can Factor XIa inhibition change prevention without raising bleeding risk?
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
